方便好用
好用
Description
血壓日記 - 一站式解決方案，用於管理血壓和血糖。這款用戶友好的應用專為高血壓和高血糖患者設計，提供簡單性、易用的導航和無廣告體驗。通過直觀的統計圖輕鬆監測和分析血壓和血健康，血壓日記 允許您立即向醫生發送全面的報告，成為您在血壓和血糖管理中的可靠助手。血壓日記 成為血壓和血糖管理領域中評價最高的應用之一。
Member automatic subscription instructions:
- As a member, you can unlock all paid features and enjoy free updates in the future.
- Automatically renews at the end of the current subscription period, unless you cancel your subscription or disable auto-renewal 24 hours before the end of the current subscription period. Once you have completed your purchase, you can manage or cancel your subscription in your App Store account settings.
Privacy Policy: https://1117d.github.io/help/private.html
User Agreement: https://1117d.github.io/help/terms.html
Hide
Show More...
Member automatic subscription instructions:
- As a member, you can unlock all paid features and enjoy free updates in the future.
- Automatically renews at the end of the current subscription period, unless you cancel your subscription or disable auto-renewal 24 hours before the end of the current subscription period. Once you have completed your purchase, you can manage or cancel your subscription in your App Store account settings.
Privacy Policy: https://1117d.github.io/help/private.html
User Agreement: https://1117d.github.io/help/terms.html
In-Apps
- Lifetime
- $490.00
- Monthly
- $60.00
- Yearly
- $290.00
Screenshots
血壓日記 FAQ
-
Is 血壓日記 free?
Yes, 血壓日記 is free to download, however it contains in-app purchases or subscription offerings.
-
Is 血壓日記 legit?
⚠️ The 血壓日記 app has poor ratings and negative feedback. Users seem unsatisfied with its performance or features.
Thanks for the vote -
How much does 血壓日記 cost?
血壓日記 has several in-app purchases/subscriptions, the average in-app price is $280.00.
-
What is 血壓日記 revenue?
To get estimated revenue of 血壓日記 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
4.82 out of 5
460 ratings in Taiwan
5 star
408
4 star
40
3 star
3
2 star
0
1 star
9
Ratings History
血壓日記 Reviews
Waste of time
Seems like nonsense to me. You can just keep a log on iphone notes
布局清楚、簡約
已內購，希望未來能添加體重記錄和生成曲線報告，對於雙高的健康管理很重要🙏
很好用
記錄挺方便的，希望可以調整高血壓值，我醫生說130以上就是高壓，這個程式是140以上才算
希望可以匯出 csv
簡單好用 希望可以匯出 csv
血糖
血糖能夠與血壓顯示圖表方便查看就更完美
有些建議
1）和健康app聯動 2）可以匯入csv 3）加入繁體中文 那就完美了！
这个软件相当好，可以记录各项数据完美
非常实用，推荐
记录好每一天的身体状态
能建立多条信息，记录每一天的变化，非常好的运用
简单实用
建议把高血压的标准设计为用户可以根据需求自行设置，这就更人性化、科学化了。
Store Rankings
Ranking History
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
154
|
|
Top Free
|
|
327
|
|
Top Free
|
|
393
|
Keywords
血壓日記 Competitors
血压日记 Installs
Last 30 days
血压日记 Revenue
Last 30 days血壓日記 Revenue and Downloads
Gain valuable insights into 血压日记 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Health Fitness
- Publisher
- 志强 王
- Languages
- Chinese, English
- Recent release
- 2.7 (3 months ago )
- Released on
- Apr 14, 2021 (3 years ago )
- Also available in
- China, Taiwan, United States, Canada, Hong Kong SAR China, United Kingdom, Australia, Thailand, India, Singapore, Malaysia, South Korea, Germany, Nigeria, Philippines, Greece, France, Netherlands, Vietnam, Portugal, Saudi Arabia, United Arab Emirates, Norway, Argentina, Italy, Ireland, Türkiye, Denmark, South Africa, Austria, Russia, Poland, Pakistan, New Zealand, Algeria, Spain, Indonesia, Egypt, Japan, Finland, Belgium, Belarus, Hungary, Romania, Chile, Colombia, Israel, Cyprus, Mexico, Kuwait, Lithuania, Switzerland, Ecuador, Iceland, Azerbaijan, Ukraine, Brunei, Brazil, Slovenia, Kazakhstan, Sweden, Estonia, Lebanon, Latvia, Madagascar, North Macedonia, Malta, Peru, Dominican Republic, Czechia
- Last Updated
- 3 days ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.